Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: Babson College
Originally published in: 2002
Version: 14 March 2002
Length: 14 pages
Data source: Published sources

Abstract

This is the seventh of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes US-based Pharmacia and Upjohn. During the period 1998-1999, the company conducted research, development, manufacturing, marketing, and sales of pharmaceutical products. Areas of focus included prescription and non-prescription drugs, chemicals, and products for food and animals. The case offers a summary of activity in these key areas. Revenue and balance sheet information is also provided. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Location:
Industry:
Size:
USD6.7 billion
Other setting(s):
1999

About

Abstract

This is the seventh of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes US-based Pharmacia and Upjohn. During the period 1998-1999, the company conducted research, development, manufacturing, marketing, and sales of pharmaceutical products. Areas of focus included prescription and non-prescription drugs, chemicals, and products for food and animals. The case offers a summary of activity in these key areas. Revenue and balance sheet information is also provided. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.

Settings

Location:
Industry:
Size:
USD6.7 billion
Other setting(s):
1999

Related